Russia eyes new Foundation for procurement of rare diseases drugs for adult patients

Global drugmakers will have an opportunity to increase sales of their drugs, particularly those for the treatment of rare diseases in the Russian market due to the recently announced plans of the state to establish a public fund for procurements of expensive innovative drugs for adults, reports The Pharma Letter’s local correspondent.

So far, such an initiative has been put forward by the All-Russian Patients' Union (VSP), according to which there is a need to establish a new fund, similar to existing “Circle of Goodness», which focuses on the purchases of drugs for people under 19 years of age with serious illnesses.

It is planned that the newly-established fund will work on the same principles and will specialize on the procurements of drugs against rare diseases for adults, including those patients, which received therapy being under the age of 19.